Total Liabilities Summary of PetMed Express, Inc.

PetMed Express, Inc.'s latest annual total liabilities in 2024 was 78.36 Million USD , up 81.42% from previous year.
PetMed Express, Inc.'s latest quarterly total liabilities in 2024 FY was 78.36 Million USD , up 94.34% from previous quarter.
PetMed Express, Inc. reported annual total liabilities of 40.32 Million USD in 2023, up 18.13% from previous year.
PetMed Express, Inc. reported annual total liabilities of 34.13 Million USD in 2022, down -26.14% from previous year.
PetMed Express, Inc. reported quarterly total liabilities of 62.41 Million USD for 2024 Q1, up 54.79% from previous quarter.
PetMed Express, Inc. reported quarterly total liabilities of 45.6 Million USD for 2024 Q2, down -26.94% from previous quarter.

Annual Total Liabilities Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Total Liabilities of PetMed Express, Inc. (2024 - 2000)

Year	Total Liabilities	Total Liabilities Growth
2024	78.36 Million USD	81.42%
2023	40.32 Million USD	18.13%
2022	34.13 Million USD	-26.14%
2021	46.21 Million USD	82.58%
2020	25.31 Million USD	28.19%
2019	19.74 Million USD	3.36%
2018	19.1 Million USD	-1.74%
2017	19.44 Million USD	174.46%
2016	7.08 Million USD	-4.49%
2015	7.41 Million USD	-9.08%
2014	8.15 Million USD	-10.99%
2013	9.16 Million USD	-7.27%
2012	9.88 Million USD	6.47%
2011	9.28 Million USD	26.93%
2010	7.31 Million USD	4.54%
2009	6.99 Million USD	8.94%
2008	6.42 Million USD	-12.7%
2007	7.35 Million USD	47.55%
2006	4.98 Million USD	27.73%
2005	3.9 Million USD	-13.01%
2004	4.48 Million USD	30.68%
2003	3.43 Million USD	11.77%
2002	3.07 Million USD	-18.04%
2001	3.74 Million USD	-20.19%
2000	4.69 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 FY	78.36 Million USD	94.34%
2024 Q1	62.41 Million USD	54.79%
2024 Q2	45.6 Million USD	-26.94%
2024 Q3	73.29 Million USD	60.72%
2024 Q4	78.36 Million USD	6.92%
2023 Q1	24.53 Million USD	-28.11%
2023 FY	40.32 Million USD	18.13%
2023 Q2	31.11 Million USD	26.79%
2023 Q3	31.53 Million USD	1.36%
2023 Q4	40.32 Million USD	27.86%
2022 FY	34.13 Million USD	-26.14%
2022 Q3	27.52 Million USD	53.79%
2022 Q4	34.13 Million USD	24.0%
2022 Q1	32.97 Million USD	-28.65%
2022 Q2	17.89 Million USD	-45.72%
2021 Q4	46.21 Million USD	63.63%
2021 Q1	29.88 Million USD	18.06%
2021 FY	46.21 Million USD	82.58%
2021 Q3	28.24 Million USD	25.31%
2021 Q2	22.54 Million USD	-24.58%
2020 Q1	21.19 Million USD	7.33%
2020 Q3	21.83 Million USD	9.47%
2020 Q4	25.31 Million USD	15.93%
2020 FY	25.31 Million USD	28.19%
2020 Q2	19.94 Million USD	-5.89%
2019 Q1	28.78 Million USD	50.67%
2019 Q4	19.74 Million USD	-17.92%
2019 Q3	24.05 Million USD	31.97%
2019 FY	19.74 Million USD	3.36%
2019 Q2	18.23 Million USD	-36.67%
2018 Q1	26.63 Million USD	36.99%
2018 Q2	20.55 Million USD	-22.81%
2018 Q3	25.61 Million USD	24.57%
2018 Q4	19.1 Million USD	-25.4%
2018 FY	19.1 Million USD	-1.74%
2017 Q1	13.43 Million USD	89.71%
2017 FY	19.44 Million USD	174.46%
2017 Q4	19.44 Million USD	136.1%
2017 Q3	8.23 Million USD	-3.83%
2017 Q2	8.56 Million USD	-36.28%
2016 Q3	7.7 Million USD	-15.81%
2016 Q4	7.08 Million USD	-8.1%
2016 FY	7.08 Million USD	-4.49%
2016 Q2	9.15 Million USD	-41.16%
2016 Q1	15.56 Million USD	109.8%
2015 Q3	6.29 Million USD	-16.97%
2015 Q1	13.88 Million USD	70.19%
2015 Q4	7.41 Million USD	17.82%
2015 FY	7.41 Million USD	-9.08%
2015 Q2	7.58 Million USD	-45.39%
2014 Q2	10.67 Million USD	-30.47%
2014 FY	8.15 Million USD	-10.99%
2014 Q4	8.15 Million USD	28.76%
2014 Q3	6.33 Million USD	-40.66%
2014 Q1	15.35 Million USD	67.56%
2013 Q3	8.66 Million USD	-6.37%
2013 Q4	9.16 Million USD	5.82%
2013 Q2	9.25 Million USD	-22.26%
2013 Q1	11.89 Million USD	20.39%
2013 FY	9.16 Million USD	-7.27%
2012 Q1	13.27 Million USD	43.02%
2012 Q2	9.04 Million USD	-31.89%
2012 FY	9.88 Million USD	6.47%
2012 Q4	9.88 Million USD	15.05%
2012 Q3	8.59 Million USD	-4.99%
2011 FY	9.28 Million USD	26.93%
2011 Q4	9.28 Million USD	56.16%
2011 Q3	5.94 Million USD	-20.26%
2011 Q2	7.45 Million USD	-43.27%
2011 Q1	13.13 Million USD	79.67%
2010 Q4	7.31 Million USD	21.24%
2010 Q1	17.32 Million USD	147.61%
2010 Q2	8.17 Million USD	-52.8%
2010 Q3	6.03 Million USD	-26.21%
2010 FY	7.31 Million USD	4.54%
2009 Q4	6.99 Million USD	-36.34%
2009 Q3	10.98 Million USD	10.22%
2009 Q2	9.96 Million USD	-31.82%
2009 Q1	14.62 Million USD	127.73%
2009 FY	6.99 Million USD	8.94%
2008 Q4	6.42 Million USD	44.21%
2008 Q1	10.89 Million USD	48.15%
2008 Q2	8.9 Million USD	-18.29%
2008 Q3	4.45 Million USD	-50.0%
2008 FY	6.42 Million USD	-12.7%
2007 Q2	6.8 Million USD	-21.89%
2007 FY	7.35 Million USD	47.55%
2007 Q3	4.5 Million USD	-33.79%
2007 Q4	7.35 Million USD	63.18%
2007 Q1	8.71 Million USD	74.83%
2006 Q2	6.73 Million USD	-6.25%
2006 Q4	4.98 Million USD	-32.48%
2006 Q3	7.38 Million USD	9.59%
2006 Q1	7.18 Million USD	84.13%
2006 FY	4.98 Million USD	27.73%
2005 Q1	7.11 Million USD	58.65%
2005 FY	3.9 Million USD	-13.01%
2005 Q4	3.9 Million USD	46.98%
2005 Q2	4.33 Million USD	-39.14%
2005 Q3	2.65 Million USD	-38.71%
2004 FY	4.48 Million USD	30.68%
2004 Q1	4.62 Million USD	34.58%
2004 Q3	4.92 Million USD	2.85%
2004 Q2	4.78 Million USD	3.65%
2004 Q4	4.48 Million USD	-8.91%
2003 Q4	3.43 Million USD	-41.47%
2003 FY	3.43 Million USD	11.77%
2003 Q3	5.86 Million USD	26.32%
2003 Q2	4.64 Million USD	22.66%
2003 Q1	3.78 Million USD	23.25%
2002 Q1	2.82 Million USD	-24.67%
2002 Q2	3.59 Million USD	27.28%
2002 Q3	3.23 Million USD	-10.04%
2002 Q4	3.07 Million USD	-4.97%
2002 FY	3.07 Million USD	-18.04%
2001 Q2	4.04 Million USD	-14.72%
2001 Q1	4.73 Million USD	0.8%
2001 Q3	3.51 Million USD	-13.0%
2001 Q4	3.74 Million USD	6.61%
2001 FY	3.74 Million USD	-20.19%
2000 FY	4.69 Million USD	0.0%
2000 Q4	4.7 Million USD	0.0%

Peer Total Liabilities Comparison of PetMed Express, Inc.

Name	Total Liabilities	Total Liabilities Difference
CannBioRx Life Sciences Corp.	5.38 Million USD	-1354.594%
BIMI International Medical Inc.	30.49 Million USD	-156.948%
China Jo-Jo Drugstores, Inc.	80.76 Million USD	2.974%
Harrow Health, Inc. 8.625% Senior Notes due 2026	241.75 Million USD	67.586%
Harrow Health, Inc. 11.875% Senior Notes due 2027	241.75 Million USD	67.586%
Leafly Holdings, Inc.	34.29 Million USD	-128.507%
Leafly Holdings, Inc.	34.29 Million USD	-128.507%
LifeMD, Inc.	52.91 Million USD	-48.092%
LifeMD, Inc.	52.91 Million USD	-48.092%
TRxADE HEALTH, Inc.	11.99 Million USD	-553.531%
Walgreens Boots Alliance, Inc.	68.85 Billion USD	99.886%

Global Stocks Search

PetMed Express, Inc. (PETS)

Total Liabilities Summary of PetMed Express, Inc.

Annual Total Liabilities Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Total Liabilities of PetMed Express, Inc. (2024 - 2000)

Peer Total Liabilities Comparison of PetMed Express, Inc.